Motilium Rx (Domperidone)

Domperidone blocks peripheral dopamine D2 receptors located in the gut and the chemoreceptor trigger zone. This blockade lifts dopamine‑mediated inhibition, increasing acetylcholine release, which stimulates coordinated smooth‑muscle contractions, speeds gastric emptying, and diminishes the brain’s perception of nausea.

The appropriate dose of Motilium Rx is determined by the prescribing healthcare professional based on the patient’s condition, age, and overall health. Dosage regimens may vary, and patients should follow the specific instructions provided by their prescriber.

Safety data for domperidone in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks before prescribing Motilium Rx to pregnant or breastfeeding individuals. Consultation with a medical professional is essential for an informed decision.

To place an order, submit an enquiry on the Motilium Rx product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Motilium Rx (domperidone) differs from other agents such as metoclopramide by acting peripherally without significant central nervous system penetration, reducing the risk of extrapyramidal side effects. Compared with ondansetron, it primarily enhances gastric motility rather than solely blocking serotonin receptors.

Motilium Rx should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keeping the product in a dry, cool place helps maintain its stability and potency throughout its shelf life.

Motilium Rx is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed, unless otherwise directed by a healthcare professional. Administration timing (e.g., before meals) follows the prescriber’s guidance.

Serious risks include cardiac arrhythmias such as QT prolongation, especially in patients with electrolyte imbalances or concurrent QT‑prolonging drugs. Rare but severe reactions may involve extrapyramidal symptoms, galactorrhea, and severe allergic responses. Prompt medical attention is required if these occur.

Motilium Rx is contraindicated in individuals with known hypersensitivity to domperidone, those with existing cardiac arrhythmias or prolonged QT interval, and patients taking other strong QT‑prolonging medications. It should also be avoided in patients with severe hepatic impairment unless specifically advised by a physician.